Effects of serotonin (5-HT)6 receptor ligands on responding for cocaine reward and seeking in rats

Pharmacological Reports

Volumn 62, Issue 6, 2010, Pages 1005-1014

  Fijał, Katarzyna ^a   Pachuta, Agnieszka ^b   McCreary, Andrew C ^c   Wydra, Karolina ^a   Nowak, Ewa ^a   Papp, Mariusz ^a   Bieñkowski, Przemysław ^d   Kotliñska, Jolanta ^b   Filip, Małgorzata ^a,e  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c Chemical Design and Synthesis Unit   (Netherlands)

^d INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^e JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cocaine; Conditioned place preference; Locomotor activity; Rats; Self administration

Indexed keywords

5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; SEROTONIN 6 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PHARMACOLOGICAL STIMULATION; PLACE PREFERENCE; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REWARD;

EID: 79551501945     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70362-5     Document Type: Article

References (52)

1. Aguilar MA, Rodríguez-Arias M, Miñarro J: Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev, 2009, 59, 253-277.
2. Broderick PA, Hope O, Okonji C, Rahni DN, Zhou Y: Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal. Prog Neuropsychopharmacol Biol Psychiatry, 2004, 28, 157-171.
3. 6 receptor antagonist. J Med Chem, 1999, 42, 202-205.
4. 6 receptor agonists in rats. Psychopharmacology, 2010, 28, 547-557.
5. 6 receptor agonist. J Med Chem, 2007, 50, 5535-5538.
6. 6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol, 2000, 130, 23-26.
7. 6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology, 2001, 25, 662-668.
8. 6 receptor antagonist. Brain Res Bull, 2003, 59, 513-521.
9. Di Chiara G: The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend, 1995, 38, 95-137.
10. Dworkin SI, Co C, Smith JE: Rat brain neurotransmitter turnover rates altered during withdrawal from chronic cocaine administration. Brain Res, 1995, 682, 116-126.
11. 6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine. Biol Psychiatry, 2008, 63, 207-213.
12. Ferraro L, Beggiato S, Marcellino D, Frankowska M, Filip M, Agnati LF, Antonelli T et al.: Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes: a novel action of cocaine. J Neural Transm, 2010, 117, 593-597.
13. 2 receptors in cocaine self-administration and seeking behavior in rats. Pharmacol Rep, 2005, 57, 35-46.
14. Filip M, Alenina N, Bader M, Przegaliñski E: Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction. Addict Biol, 2010, 15, 227-249.
15. Filip M, Bader M: Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol Rep, 2009, 61, 761-777.
16. Filip M, Frankowska M: GABA(B) receptors in drug addiction. Pharmacol Rep, 2008, 60, 755-770.
17. 6 receptor on formalin-evoked nociceptive behaviour, locomotor activity and hypothalamo-pituitary-adrenal axis activity in rats. Eur J Pharmacol, 2007, 569, 59-63.
18. Fone KC: An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function. Neuropharmacology, 2008, 55, 1015-1022.
19. Frankowska M, Gołda A, Wydra K, Gruca P, Papp M, Filip M: Effects of imipramine or GABAB receptor ligands on the immobility, swimming and climbing in the forced swim test in rats following discontinuation of cocaine self-administration. Eur J Pharmacol, 2010, 627, 142-149.
20. 6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine. Neuropharmacology, 2002, 42, 170-180.
21. Hall FS, Li XF, Randall-Thompson J, Sora I, Murphy DL, Lesch KP, Caron M et al.: Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. Neuroscience, 2009, 162, 870-880.
22. 6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease. Life Sci, 2009, 84, 558-562.
23. 6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur J Pharmacol, 2006, 553, 109-119.
24. Homberg JR, De Boer SF, Raasø HS, Olivier JD, Verheul M, Ronken E, Cools AR et al.: Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats. Psychopharmacology, 2008, 200, 367-380.
25. Koe BK: Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther, 1976, 199, 649-661.
26. Koob GF: Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry, 2009, 42, 32-41.
27. Koob GF, Bloom FE: Cellular and molecular mechanisms of drug dependence. Science, 1988, 242, 715-723.
28. Kuhar MJ, Ritz MC, Boja JW: The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci, 1991, 14, 299-302.
29. 6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus. Brain Res, 2007, 1134, 70-78.
30. Maldonado C, Rodríguez-Arias M, Castillo A, Aguilar MA, Miñarro J: Effect of memantine and CNQX in the acquisition, expression and reinstatement of cocaine-induced conditioned place preference. Prog Neuropsychopharmacol Biol Psychiatry, 2007, 31, 932-939. (Pubitemid 46660306)
31. Marcellino D, Navarro G, Sahlholm K, Nilsson J, Agnati LF, Canela EI, Lluís C et al.: Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer. Biochem Biophys Res Commun, 2010, 394, 988-992.
32. Marcos B, Aisa B, Ramírez MJ: Functional interaction between 5-HT6 receptors and hypothalamic-pituitary-adrenal axis: cognitive implications. Neuropharmacology, 2008, 54, 708-714.
33. Marcos B, Gil-Bea FJ, Hirst WD, García-Alloza M, Ramírez MJ: Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. Eur J Neurosci, 2006, 24, 1299-1306.
34. Parsons LH, Koob GF, Weiss F: Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther, 1995, 274, 1182-1191.
35. 6 antagonist MS-245. Pharmacol Biochem Behav, 2004, 78, 263-268.
36. Rebec GV, Sun W: Neuronal substrates of relapse to cocaine-seeking behavior: role of prefrontal cortex. J Exp Anal Behav, 2005, 84, 653-666.
37. 6 receptor antagonist. J Med Chem, 2003, 46, 1273-1276.
38. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ: Cocaine self-administration appears to be mediated by dopamine uptake inhibition. Prog Neuropsychopharmacol Biol Psychiatry, 1988, 12, 233-239.
39. Robbins TW, Ersche KD, Everitt BJ: Drug addiction and the memory systems of the brain. Ann NY Acad Sci, 2008, 1141, 1-21.
40. 6 receptor antagonist. Br J Pharmacol, 2000, 130, 1606-1612.
41. Rutten K, van der Kam EL, De Vry J, Bruckmann W, Tzschentke TM: The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats. Addict Biol, 2011, 16, 108-115.
42. Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B, Brandt MR et al.: Neuropharmacological profile of novel and selective 5-HT6 receptor agonists:WAY-181187 and WAY-208466. Neuropsychopharmacology, 2008, 33, 1323-1335.
43. Schmidt HD, Anderson SM, Famous KR, Kumaresan V, Pierce RC: Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking. Eur J Pharmacol, 2005, 526, 65-76. (Pubitemid 41744106)
44. See RE: Neural substrates of cocaine-cue associations that trigger relapse. Eur J Pharmacol, 2005, 526, 140-146.
45. Sizemore GM, Co C, Smith JE: Ventral pallidal extracellular fluid levels of dopamine, serotonin, gamma amino butyric acid, and glutamate during cocaine selfadministration in rats. Psychopharmacology, 2000, 150, 391-398. (Pubitemid 30470217)
46. Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB, Wichems C, et al.: Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA, 2001, 98, 5300-5305.
47. Thomsen M, Hall FS, Uhl GR, Caine SB: Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J Neurosci, 2009, 29, 1087-1092.
48. 6 antagonism attenuates cue-induced relapse to cocaine seeking without affecting cocaine reinforcement. Int J Neuropsychopharmacol, 2010, 13, 961-965.
49. 6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology, 2007, 52, 1274-1283.
50. 6 receptor antagonist SB-258585 after intrahippocampal administration to rats. Behav Pharmacol, 2007, 18, 439-446.
51. West PJ, Marcy VR, Marino MJ, Schaffhauser H: Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus. Neuroscience, 2009, 164, 692-701.
52. 6 receptor antagonist, Ro 04-6790. Psychopharmacology, 2003, 170, 358-367.